FLUCONAZOLE, 50mg/5ml, powder oral susp., bot.

STD DORAFLUC1S-

Valid Article

Former Code(s): -X
Article is intended to be used with children (<12 years) ONLY.
6.3 - Antifungal medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J02AC01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

FLUCONAZOLE

Therapeutic Action

Systemic antifungal, mainly active against Candida albicans and Cryptococcus neoformans

Indications

Oesophageal candidiasis

Moderate to severe oropharyngeal candidiasis

Secondary prophylaxis of recurrent candidiasis in immunocompromised patients

Cryptococcal meningitis

Secondary prophylaxis of cryptococcal infections

Instructions for use

The dosage is different depending on the indications.

The oral suspension is intended for paediatric use. To be reconstituted with filtered water.

Storage

  • Below 25°C ‐ Protect from sunlight
  • After reconstitution, the oral suspension keeps for 2 weeks. Do not freeze.